Contract awardedMedicines supply

Botulinum antitoxin for UKHSA's stockpile comes from Emergent BioSolutions

UK Health Security Agency (UKHSA) is buying Botulinum Antitoxin Heptavalent (HBAT) from Emergent BioSolutions Canada Inc. The supply will support national health security stockpiling.

Before the tender, UKHSA asked suppliers about the products available, pack sizes and minimum order quantities. Commercial terms counted for 80% of the score, with social value and technical risk at 10% each.

One bid came in. The award was made in October 2026 without a published value, and the two-year contract can be extended to November 2030.

Alert me to similar tenders

Contract ends November 2028

What
Medicines supply
Value
Not published
How it was bought
Competitive flexible procedure
1 bid
Dates and next
Nov 2026 to Nov 2028
Option to Nov 2030

How it was bought

3 official notices
  1. 26 Jun 2026Planning noticeFind a Tender
  2. 15 Jul 2026Tender noticeFind a Tender
  3. 13 Aug 2026Bids closed1 bid
  4. 26 Oct 2026Award noticeFind a Tender
  5. 16 Nov 2026Contract starts
  6. 15 Nov 2028Contract endsUp to Nov 2030 with extension

UK Health Security Agency has bought this 12 or more times since 2021

Last bought
Nov 2026
Typical length
1.5 years
Typical value
£30,897
Suppliers used
9
in its last 12 purchases
AwardedContractWon byValue
Nov 2026Locked2 yearsLocked·
Oct 2026This purchase2 yearsEmergent BioSolutions Canada Inc·
Dec 2025Locked3 monthsLocked·
Nov 2025Locked11 monthsLocked·
Oct 2025Locked1 yearLocked·

and at least 7 more

Suppliers UK Health Security Agency has used in its last 12 purchases

SupplierContractsValue
Locked3·
Locked2·
Locked1£33,455
Locked1£28,339
Emergent BioSolutions Canada Inc Won this one1·

and 4 more

See the contracts and who won them

Figures to 21 November 2026

How it compares

With every medicines supply award since 2021

Half of awards fall between £200,000 and £1.98mMedian £500,000

Awards
438
Firms that won them
277
Median award
£500,000
of 360 with a value
Typical length
2 years

Emergent BioSolutions Canada Inc ranks 137th of 277 firms for medicines supply awards since 2021.

RankFirmAwardsValue
1Locked38£6.93m
2Locked33£32.8m
3Locked31£25.6m
4Locked30£146.9m
4Locked30£12.7m
6Locked28£25.6m
137Emergent BioSolutions Canada Inc Won this one2£4.32m
See who wins this work

Medicines supply at other buyers

UK Health Security Agency has awarded 2,546 contracts since 2021.

See UK Health Security Agency's page
  • Emergent BioSolutions Canada Inc has won 3 public contracts since 2021.

1 medicines supply tender is open now

See it
More medicines supply contracts awarded in 2026